Ingersoll Rand Inc.
Ingersoll Rand Inc. (IR) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Ingersoll Rand Inc. (IR), featuring income statements, balance sheets, and cash flow data.
Ingersoll Rand Inc. (IR) Income Statement & Financial Overview
Analyze Ingersoll Rand Inc.’s IR earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.72B | $1.90B | $1.86B | $1.81B |
| Cost of Revenue | $951.30M | $1.08B | $1.05B | $1.10B |
| Gross Profit | $765.50M | $815.40M | $815.00M | $702.10M |
| Gross Profit Ratio | $0.45 | $0.43 | $0.44 | $0.39 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $350.00M | $331.70M | $334.30M | $342.10M |
| Operating Expenses | $463.00M | $436.60M | $334.30M | $341.70M |
| Total Costs & Expenses | $1.41B | $1.32B | $1.38B | $1.44B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $61.20M | $61.80M | $63.80M | $50.80M |
| Depreciation & Amortization | -$11.80M | $122.70M | $124.30M | $116.90M |
| EBITDA | $302.50M | $510.50M | $497.60M | $477.70M |
| EBITDA Ratio | $0.18 | $0.27 | $0.27 | $0.26 |
| Operating Income | $302.50M | $378.80M | $356.30M | $360.40M |
| Operating Income Ratio | $0.18 | $0.20 | $0.19 | $0.20 |
| Other Income/Expenses (Net) | -$49.40M | -$53.70M | -$54.30M | -$35.70M |
| Income Before Tax | $253.10M | $325.10M | $302.00M | $236.10M |
| Income Before Tax Ratio | $0.15 | $0.17 | $0.16 | $0.13 |
| Income Tax Expense | $58.50M | $88.20M | $73.80M | $46.10M |
| Net Income | $186.50M | $229.80M | $221.60M | $185.00M |
| Net Income Ratio | $0.11 | $0.12 | $0.12 | $0.10 |
| EPS | $0.46 | $0.57 | $0.55 | $0.46 |
| Diluted EPS | $0.46 | $0.57 | $0.54 | $0.45 |
| Weighted Avg Shares Outstanding | $403.40M | $403.45M | $403.50M | $403.50M |
| Weighted Avg Shares Outstanding (Diluted) | $407.20M | $406.60M | $406.90M | $407.40M |
Over the past four quarters, Ingersoll Rand Inc. demonstrated steady revenue growth, increasing from $1.81B in Q2 2024 to $1.72B in Q1 2025. Operating income reached $302.50M in Q1 2025, maintaining a consistent 18% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $302.50M, reflecting operational efficiency. Net income dropped to $186.50M, with EPS at $0.46. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan